2025-04-12_00000112
|
ligand
|
9BBT
SARS-CoV-2 Mpro in complex with compound 6f inhibitor;
X-ray diffraction 2.57Å
Protein #1
306 residues (99% resolved)
Raw Sequence ...
SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ
Canonical Sequence ...
SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ
Non polymer #2
A1ALH
InChI=1S/C28H36N4O5/c1-17(2)13-23(28(35)31-22(16-29)14-21-11-12-30-26(21)33)32-27(34)19-7-5-18(6-8-19)20-9-10-24(36-3)25(15-20)37-4/h5-10,15-17,21-23,29H,11-14H2,1-4H3,(H,30,33)(H,31,35)(H,32,34)/b29-16+/t21-,22?,23-/m0/s1
InChI=1S/C28H36N4O5/c1-17(2)13-23(28(35)31-22(16-29)14-21-11-12-30-26(21)33)32-27(34)19-7-5-18(6-8-19)20-9-10-24(36-3)25(15-20)37-4/h5-10,15-17,21-23,29H,11-14H2,1-4H3,(H,30,33)(H,31,35)(H,32,34)/b29-16+/t21-,22?,23-/m0/s1
SMILES: CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3ccc(c(c3)OC)OC
CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3ccc(c(c3)OC)OC
Biounit #1
monomer
Download coordinates
Tube
Model
Reference
100%